Jalloul, W.; Ghizdovat, V.; Saviuc, A.; Jalloul, D.; Grierosu, I.C.; Stefanescu, C.
Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac-PSMA and Its Relevance Compared with [177Lu]Lu-PSMA in Advanced Prostate Cancer Management. Pharmaceuticals 2025, 18, 1215.
https://doi.org/10.3390/ph18081215
AMA Style
Jalloul W, Ghizdovat V, Saviuc A, Jalloul D, Grierosu IC, Stefanescu C.
Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac-PSMA and Its Relevance Compared with [177Lu]Lu-PSMA in Advanced Prostate Cancer Management. Pharmaceuticals. 2025; 18(8):1215.
https://doi.org/10.3390/ph18081215
Chicago/Turabian Style
Jalloul, Wael, Vlad Ghizdovat, Alexandra Saviuc, Despina Jalloul, Irena Cristina Grierosu, and Cipriana Stefanescu.
2025. "Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac-PSMA and Its Relevance Compared with [177Lu]Lu-PSMA in Advanced Prostate Cancer Management" Pharmaceuticals 18, no. 8: 1215.
https://doi.org/10.3390/ph18081215
APA Style
Jalloul, W., Ghizdovat, V., Saviuc, A., Jalloul, D., Grierosu, I. C., & Stefanescu, C.
(2025). Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac-PSMA and Its Relevance Compared with [177Lu]Lu-PSMA in Advanced Prostate Cancer Management. Pharmaceuticals, 18(8), 1215.
https://doi.org/10.3390/ph18081215
